As an example, recent studies identified a crucial role for LPI signaling in metabolic disorders leading to nonalcoholic steatohepatitis, a degenerative disorder of the liver that leads to steatosis and fibrosis in which both GPR55 and LPI are upregulated [71]. Here, GPR55 is linked to Other metabolic disease.